Tissue Repair Ltd (TRP) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.091x

Based on the latest financial reports, Tissue Repair Ltd (TRP) has a cash flow conversion efficiency ratio of -0.091x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.26 Million ≈ $-891.91K USD) by net assets (AU$13.91 Million ≈ $9.84 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Tissue Repair Ltd - Cash Flow Conversion Efficiency Trend (2020–2025)

This chart illustrates how Tissue Repair Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read TRP total liabilities for a breakdown of total debt and financial obligations.

Tissue Repair Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tissue Repair Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Nextage Therapeutics Ltd
TA:NXTG
0.311x
JLT Mobile Computers AB (publ)
ST:JLT
0.071x
Witbe Net SA
PA:ALWIT
0.366x
FIREFOX GOLD CORP.
F:FIY
N/A
CXApp Inc.
NASDAQ:CXAI
-0.181x
Till Capital Ltd
V:TIL
-0.014x
Global Interactive Technologies, Inc
NASDAQ:GITS
-0.032x
Lion Energy Ltd
AU:LIO
-0.111x

Annual Cash Flow Conversion Efficiency for Tissue Repair Ltd (2020–2025)

The table below shows the annual cash flow conversion efficiency of Tissue Repair Ltd from 2020 to 2025. For the full company profile with market capitalisation and key ratios, see TRP market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$13.91 Million
≈ $9.84 Million
AU$-3.70 Million
≈ $-2.62 Million
-0.266x +3.12%
2024-06-30 AU$18.04 Million
≈ $12.76 Million
AU$-4.95 Million
≈ $-3.50 Million
-0.274x -41.14%
2023-06-30 AU$21.88 Million
≈ $15.48 Million
AU$-4.26 Million
≈ $-3.01 Million
-0.194x -24.24%
2022-06-30 AU$25.34 Million
≈ $17.93 Million
AU$-3.97 Million
≈ $-2.81 Million
-0.157x -396.87%
2021-06-30 AU$27.07 Million
≈ $19.16 Million
AU$-852.89K
≈ $-603.47K
-0.032x +95.15%
2020-06-30 AU$999.90K
≈ $707.50K
AU$-649.98K
≈ $-459.91K
-0.650x --

About Tissue Repair Ltd

AU:TRP Australia Biotechnology
Market Cap
$5.78 Million
AU$8.16 Million AUD
Market Cap Rank
#28075 Global
#1515 in Australia
Share Price
AU$0.14
Change (1 day)
+0.00%
52-Week Range
AU$0.13 - AU$0.41
All Time High
AU$0.70
About

Tissue Repair Ltd, a clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. The company utilizes Glucoprime technology, an immunogenic active pharmaceutical ingredient that activates macrophages and stimulates immune response for wound healing and skin regeneration. It develops TR-987, a topical … Read more